These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8335982)

  • 1. Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice.
    Kullberg BJ; van 't Wout JW; Hoogstraten C; van Furth R
    J Infect Dis; 1993 Aug; 168(2):436-43. PubMed ID: 8335982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1.
    Kullberg BJ; van 't Wout JW; van Furth R
    Infect Immun; 1990 Oct; 58(10):3319-24. PubMed ID: 2144844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interleukin-18 protects against disseminated Candida albicans infection in mice.
    Stuyt RJ; Netea MG; van Krieken JH; van der Meer JW; Kullberg BJ
    J Infect Dis; 2004 Apr; 189(8):1524-7. PubMed ID: 15073691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of granulocytes and monocytes to resistance against experimental disseminated Candida albicans infection.
    van 't Wout JW; Linde I; Leijh PC; van Furth R
    Eur J Clin Microbiol Infect Dis; 1988 Dec; 7(6):736-41. PubMed ID: 3145854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inability of recombinant interferon-gamma to activate the antibacterial activity of mouse peritoneal macrophages against Listeria monocytogenes and Salmonella typhimurium.
    van Dissel JT; Stikkelbroeck JJ; Michel BC; van den Barselaar MT; Leijh PC; van Furth R
    J Immunol; 1987 Sep; 139(5):1673-8. PubMed ID: 2957433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effect of cyclosporin A on resistance to systemic infection with Candida albicans.
    Vecchiarelli A; Cenci E; Marconi P; Rossi R; Riccardi C; Bistoni F
    J Med Microbiol; 1989 Nov; 30(3):183-92. PubMed ID: 2511321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.
    Sawyer RT; Harmsen AG
    Mycopathologia; 1989 Nov; 108(2):95-105. PubMed ID: 2687694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant murine granulocyte colony-stimulating factor protects against acute disseminated Candida albicans infection in nonneutropenic mice.
    Kullberg BJ; Netea MG; Curfs JH; Keuter M; Meis JF; van der Meer JW
    J Infect Dis; 1998 Jan; 177(1):175-81. PubMed ID: 9419185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.
    Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE
    Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.
    Langermans JA; van der Hulst ME; Nibbering PH; van der Meide PH; van Furth R
    Immunology; 1992 Nov; 77(3):354-61. PubMed ID: 1478682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
    Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ
    J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
    Hockertz S
    Arzneimittelforschung; 1997 Jun; 47(6):793-6. PubMed ID: 9239462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma interferon is not essential in host defense against disseminated candidiasis in mice.
    Qian Q; Cutler JE
    Infect Immun; 1997 May; 65(5):1748-53. PubMed ID: 9125557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of Candida albicans infections of haematogenous and mucosal origin in mice lacking the interferon gamma receptor protein.
    Londono LP; Jones HB; Vie AT; McPheat WL; Booth G; Gao XM; Dougan G
    FEMS Immunol Med Microbiol; 2000 Feb; 27(2):117-25. PubMed ID: 10640606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.
    Langermans JA; van der Hulst ME; Nibbering PH; van Furth R
    Infect Immun; 1992 Dec; 60(12):5107-12. PubMed ID: 1452344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of interleukin-18 in host defense against disseminated Candida albicans infection.
    Stuyt RJ; Netea MG; Verschueren I; Fantuzzi G; Dinarello CA; Van Der Meer JW; Kullberg BJ
    Infect Immun; 2002 Jun; 70(6):3284-6. PubMed ID: 12011026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-13 attenuates early local CXCL2-dependent neutrophil recruitment for Candida albicans clearance during a severe murine systemic infection.
    Abe Y; Yamamoto N; Nakamura K; Arai K; Sakurai C; Hatsuzawa K; Ogura Y; Iseki K; Tase C; Kanemitsu K
    Immunobiology; 2019 Jan; 224(1):15-29. PubMed ID: 30514570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40/CD40 ligand interactions in the host defense against disseminated Candida albicans infection: the role of macrophage-derived nitric oxide.
    Netea MG; Meer JW; Verschueren I; Kullberg BJ
    Eur J Immunol; 2002 May; 32(5):1455-63. PubMed ID: 11981834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of host resistance to Candida albicans infection in ascites tumor-bearing mice.
    Okawa Y; Murata Y; Kobayashi M; Suzuki M; Suzuki S
    Microbiol Immunol; 1992; 36(5):517-21. PubMed ID: 1513264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.